Today: 8 July 2026
Redwire Dips After $500 Million ATM Offering
10 June 2026
2 mins read

Redwire Dips After $500 Million ATM Offering

New York, June 10, 2026, 06:07 (EDT)

  • Redwire shares fell 15.19% to end Tuesday at $15.75 after the company filed for a $500 million at-the-market stock sale.
  • Redwire sold $349,999,993.77 through a May 2026 equity program before ending it, according to the filing.
  • Investors need to pay attention to the real share sales, not only the overall facility size. Redwire said it will update on sales, proceeds and what it paid agents at least once a quarter.

Redwire Corporation (RDW) faces selling pressure Wednesday after the company revealed in an SEC filing it could sell up to $500 million in common stock through an at-the-market offering. That set-up allows Redwire to drip shares into the market instead of flooding it all at once. Shareholders have dilution in focus, since more shares could mean smaller pieces of the pie. RDW finished Tuesday at $15.75, dropping 15.19% from Monday’s close of $18.57.

Redwire shares dropped, but it wasn’t driven by earnings or a lost deal. Supply was the issue. In a prospectus supplement filed June 9, the company said it struck an equity distribution agreement with Truist Securities, J.P. Morgan, BofA Securities and others to sell up to $500 million in stock.

The main shift is in how much and how fast Redwire can tap into equity. According to the prospectus, Redwire already sold $349,999,993.77 in common stock through a May 2026 equity deal, which the company ended June 9. The new facility brings the market’s focus from whether Redwire can raise money to how much new stock might hit the market.

The filing spells out why traders moved fast. At the June 8 NYSE close of $18.57 a share, selling the whole $500 million would mean Redwire putting out 26,925,148 new shares and lifting the total to as many as 265,750,493 shares out. That’s about an 11% jump from the 238,825,345 that were outstanding as of June 8. The actual dilution could change, since the price of future sales will set the number.

Redwire says it doesn’t have to sell any shares under the agreement and can pause the offering whenever it wants. Any sales could go through the NYSE, other trading venues, market makers, block trades, or private deals. Agents could get up to 3% of the gross sales price per share.

The company said it could use net proceeds for working capital, to pay down or refinance debt, make acquisitions or investments, or fund research and development. Shares dropped. Investors tend to favor flexibility, but they often sell on plans for open-ended share sales like this—unless the cash is set to drive up per-share growth.

Some say it’s smart to raise cash when you can. Redwire’s latest quarter showed revenue at $97.0 million, up 57.9% from a year ago, and backlog rising to a record $498.1 million. The company also kept its 2026 revenue outlook at $450 million to $500 million.

Redwire’s latest update put a spotlight on why more cash is still needed. The company reported a first-quarter net loss of $76.5 million. Adjusted EBITDA came in at minus $9.2 million. Adjusted EBITDA, which is a non-GAAP figure that cuts out interest, taxes, depreciation, amortization and some other items, still landed below zero for Redwire.

Liquidity was in place. At the end of March, Redwire reported $175.2 million in total liquidity. That included $144.5 million in cash and cash equivalents, $30.0 million of borrowing capacity, and $0.7 million in restricted cash. The new ATM shows management is seeking more flexibility as it looks to fund work in space systems, defense tech, autonomous aerial systems, and microgravity infrastructure.

Balanced risk looks simple. If Redwire pushes out a lot of stock while shares are weak, more supply could weigh on RDW and dilute holders before Redwire shows higher cash flow from the deal. The prospectus says management gets wide latitude over how to use the cash, more sales can dilute ownership, and just the idea of big public sales can push the stock down.

The main thing to watch now is pace, not the size of the shelf. That number is out. Redwire said it will update shareholders at least every quarter on how many shares it sold, net proceeds, and what it paid agents. The next routine filing will be the first clear look at whether Tuesday’s dilution worries are turning into real share sales.

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation.

Stock Market Today

  • Scipher Medicine to Buy Chemomab Therapeutics in All-Stock Merger, Gains RA Drug and Nasdaq Listing
    July 8, 2026, 9:51 AM EDT. Scipher Medicine said it will acquire Chemomab Therapeutics in an all-stock merger. Chemomab's rheumatoid arthritis (RA) drug will join Scipher's pipeline as it builds out its autoimmune disease portfolio. The deal will also put Scipher on the Nasdaq, giving it access to the public markets. Scipher is looking to grow its range of targeted immunology drugs with Chemomab's RA candidate. Both groups are betting the combined company can compete in the biotech space targeting immune-related conditions.
Nokia Drops 7% After Nvidia 6G Chatter Hits AI Stocks
Previous Story

Nokia Drops 7% After Nvidia 6G Chatter Hits AI Stocks

Why Aurora Innovation Stock Is Falling as Uber’s $479 Million Share Sale Tests the Driverless Truck Rally
Next Story

Why Aurora Innovation Stock Is Falling as Uber’s $479 Million Share Sale Tests the Driverless Truck Rally

Go toTop